Metrosouth Urology

Urologic Expertise and Care For You

Prostate Cancer Risk, Aggressiveness Tied to Socioeconomics

December 20, 2018 Share this content: Study of Canadian men looked at the association between prostate cancer and participants’ socioeconomic position during childhood/adolescence and early and late adulthood. Disadvantageous socioeconomic position (SEP) over the course of a man’s lifetime is as...
Read More

Prostate Cancer Detection Improved With Combined Biopsy Targeting

December 20, 2018 Share this content: In a study, visual registration in conjunction with image fusion resulted in the highest detection rate of clinically significant prostate cancer. Visual registration in combination with image fusion may offer the highest detection rate of clinically significant...
Read More

Gleason 6 Prostate Cancer More Lethal in Black Men

December 18, 2018 Share this content: Black men with Gleason 6 prostate cancer had a 1.5- to 2.0-fold increased risk of dying from their cancer compared with nonblack men, according to a new study. Black men are more likely than white men to die from Gleason 6 prostate cancer (PCa), according to inv...
Read More

Statins Plus ADT May Up Survival in Advanced Prostate Cancer

December 18, 2018 Share this content: Statin use by men receiving ADT for advanced PCa was associated with decreased risk of overall and cancer-specific mortality. Statin use by men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa) is associated with improved overall and cancer-...
Read More

Genetic Differences in Prostate Cancer Pinpointed in Black Men

October 16, 2018 Share this content: New findings relating to genetic differences in prostate cancer findings could help explain why men of African ancestry are more likely than white men to die from the malignancy. French investigators have zeroed in on genetic mutations that could provide clues to...
Read More

Study Zeroes in on Cause of Castration-Resistant Prostate Cancer

September 19, 2018 Share this content: New study findings may explain why prostate cancer becomes resistant to androgen deprivation therapy. Development of castration-resistant prostate cancer (CRPC) may be due to a lack of androgen receptor expression in prostate cancer cells, identifying a potenti...
Read More